Synthesis and identification of conformationally constrained selective MMP inhibitors

被引：34

作者：

Freskos, JN ^{[1
]}

McDonald, JJ ^{[1
]}

Mischke, BV ^{[1
]}

Mullins, PB ^{[1
]}

Shieh, HS ^{[1
]}

Stegeman, RA ^{[1
]}

Stevens, AM ^{[1
]}

机构：

[1] Searle Discovery Res, Dept Med Chem, St Louis, MO 63198 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 1999年 / 9卷 / 13期

关键词：

D O I：

10.1016/S0960-894X(99)00285-1

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

引用

页码：1757 / 1760

页数：4

共 6 条

[1] Discovery of a novel series of selective MMP inhibitors:: Identification of the γ-sulfone-thiols [J].

Freskos, JN ;

Mischke, BV ;

DeCrescenzo, GA ;

Heintz, R ;

Getman, DP ;

Howard, SC ;

Kishore, NN ;

McDonald, JJ ;

Munie, GE ;

Rangwala, S ;

Swearingen, CA ;

Voliva, C ;

Welsch, DJ .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (07) :943-948

[2] A NOVEL COUMARIN-LABELED PEPTIDE FOR SENSITIVE CONTINUOUS ASSAYS OF THE MATRIX METALLOPROTEINASES [J].

KNIGHT, CG ;

WILLENBROCK, F ;

MURPHY, G .

FEBS LETTERS, 1992, 296 (03) :263-266

[3] Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage [J].

Mitchell, PG ;

Magna, HA ;

Reeves, LM ;

LoprestiMorrow, LL ;

Yocum, SA ;

Rosner, PJ ;

Geoghegan, KF ;

Hambor, JE .

JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (03) :761-768

[4]

OBRYNE EM, 1995, INFLAMM RES, V44, pS177

[5] BIOLOGICAL EVALUATION OF MATRIX METALLOPROTEINASE INHIBITORS, 18 MAY 1995, NEW-YORK [J].

PRATTA, MA .

INFLAMMATION RESEARCH, 1995, 44 (11) :458-460

[6] Phase I trial of marimastat, a novel matrix metalloproteinase inhibitor, administered orally to patients with advanced lung cancer [J].

Wojtowicz-Praga, S ;

Torri, J ;

Johnson, M ;

Steen, V ;

Marshall, J ;

Ness, E ;

Dickson, R ;

Sale, M ;

Rasmussen, HS ;

Chiodo, TA ;

Hawkins, MJ .

JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (06) :2150-2156

← 1 →